HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indoleamine 2,3-dioxygenase in tumor induced tolerance.

AbstractOBJECTIVE:
To review the recent studies about the role of indoleamine 2,3-dioxygenase (IDO) in tumor induced tolerance.
DATA SOURCES:
Published articles (1978 - 2009) on IDO and tumor induced tolerance were selected from Medline.
STUDY SELECTION:
Articles selected were relevant to development of IDO in tumor induced tolerance. Of all originally identified articles, 50 specially addressed the stated purpose.
RESULTS:
Recent work has revealed IDO at high levels in tumors and in tumor-draining lymph nodes and a close relationship between IDO activity and the regulatory T cells.
CONCLUSION:
Up-regulation of IDO is proven to be a mechanism of acquired tolerance in tumors, in which the closely coupled positive feedback system between IDO and regulatory T cells may be considered to play an important role.
AuthorsXiao-Qian Liu, Xin Wang
JournalChinese medical journal (Chin Med J (Engl)) Vol. 122 Issue 24 Pg. 3072-7 (Dec 20 2009) ISSN: 2542-5641 [Electronic] China
PMID20137504 (Publication Type: Journal Article, Review)
Chemical References
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
Topics
  • Animals
  • Gene Expression Regulation, Neoplastic (physiology)
  • Humans
  • Immune Tolerance (physiology)
  • Indoleamine-Pyrrole 2,3,-Dioxygenase (metabolism)
  • Neoplasms (enzymology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: